In line with the global industry’s commitment to innovation in India, PricewaterhouseCoopers (PwC) had been commissioned to assess the innovation landscape of the Indian pharmaceutical industry and to suggest policy recommendations to help India move up the innovation value chain. PwC presented their initial findings, which highlighted the need for India to strengthen four pillars of innovation: Infrastructure; financing; human resource, legal and IPR and regulatory, in order to create an environment conducive to innovation and able to attract global investment. The visiting leaders shared their thoughts on the industry’s potential, especially relating to pharmaceutical innovation in India. The global delegation met with top Indian government officials, academic experts, and business leaders. They encouraged support for innovation in India, including the development of new solutions to treat patients suffering from rare diseases and new medicines to save and improve lives.

(Pharma Biz)